Bunyamin Bulkurcuoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bunyamin Bulkurcuoglu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Sebnem Ercelen Ceylan
Department of Biophysics, Hamidiye Faculty of Medicine University of Health Sciences İstanbul Türkiye
3 shared publications - Aise Rumeysa Mazi
Department of Biophysics, Hamidiye Faculty of Medicine, University of Health Sciences
1 shared publication - Alexander Zaichenko
Lviv Polytechnic National University
1 shared publication - Ali Akpek
Yildiz Teknik Üniversitesi
1 shared publication - Ayse Nalbantsoy
Ege University
1 shared publication Ayça Bal-Ozturk
Department of Analytical Chemistry, Faculty of Pharmacy, İstinye University, 34010, Zeytinburnu, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
Bioinspired Cross-Linked Anionic Hydrogel Microparticles as Potential Adjuvants for Safe Vaccines: Colloidal-Chemical Characteristics, Morphology and Biological Properties
Novel anionic cross-linked hydrogel-based microparticles with controlled size, functionality, porosity, and morphology were synthesized via tailored precipitation polymerization of hydrophobic and hydrophilic monomers in the presence of dimethacrylate as a cross-linking agent. The resulting hydrogel microparticles (HG5), with a size of 250 ± 50 nm and a polydispersity index of 0.079, were readily dispersible in water and formed stable suspensions at physiological pH (7.2–7.4). Their physicochemical properties were comprehensively characterized using FT-IR, NMR, DLS, SAXS, TEM, and turbidimetry. HG5 efficiently incorporated albumin as a model antigen with a loading efficiency of 95%, forming stable hydrogel–protein complexes that maintained their hydrodynamic size and colloidal stability over one month of storage. Biological evaluation demonstrated low toxicity toward pseudonormal cell lines, with cell viability remaining above 50% at concentrations up to 5 mg/mL and no detectable apoptotic effects in HEK293 cells. Human peripheral blood mononuclear cells (PBMCs) were sensitive to HG5 exposure, exhibiting an IC50 of 0.52 mg/mL, while showing good hemocompatibility with hemolysis below 5%. HG5 significantly enhanced immunogenicity, increasing BSA-specific antibody levels by 1.9-fold compared to the immunization without adjuvant (p < 0.05). These findings demonstrate the potential of HG5 as a versatile platform for protein delivery and vaccine adjuvant development.
Open AccessBioinspired Cross-Linked Anionic Hydrogel Microparticles as Potential Adjuvants for Safe Vaccines: Colloidal-Chemical Characteristics, Morphology and Biological Properties
Novel anionic cross-linked hydrogel-based microparticles with controlled size, functionality, porosity, and morphology were synthesized via tailored precipitation polymerization of hydrophobic and hydrophilic monomers in the presence of dimethacrylate as a cross-linking agent. The resulting hydrogel microparticles (HG5), with a size of 250 ± 50 nm and a polydispersity index of 0.079, were readily dispersible in water and formed stable suspensions at physiological pH (7.2–7.4). Their physicochemical properties were comprehensively characterized using FT-IR, NMR, DLS, SAXS, TEM, and turbidimetry. HG5 efficiently incorporated albumin as a model antigen with a loading efficiency of 95%, forming stable hydrogel–protein complexes that maintained their hydrodynamic size and colloidal stability over one month of storage. Biological evaluation demonstrated low toxicity toward pseudonormal cell lines, with cell viability remaining above 50% at concentrations up to 5 mg/mL and no detectable apoptotic effects in HEK293 cells. Human peripheral blood mononuclear cells (PBMCs) were sensitive to HG5 exposure, exhibiting an IC50 of 0.52 mg/mL, while showing good hemocompatibility with hemolysis below 5%. HG5 significantly enhanced immunogenicity, increasing BSA-specific antibody levels by 1.9-fold compared to the immunization without adjuvant (p < 0.05). These findings demonstrate the potential of HG5 as a versatile platform for protein delivery and vaccine adjuvant development.
- Open Access
- 17 November 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (11) , e202400362
Multifunctional PAMAM Dendrimers Carrying SAHA, 5‐FU, and a Therapeutic Gene for Targeted Co‐Delivery Toward Colorectal Cancer Cells
A promising approach to treat colorectal cancer (CRC) involves combining chemotherapy, epigenetics, and gene therapy to combat drug resistance. Multifunctional nanocarriers have emerged as a valuable tool for targeted CRC therapy. By delivering multiple treatments directly to cancer cells, these nanocarriers offer the potential for improved outcomes and reduced side effects. PAMAM‐based dendrimers were functionalized with a unique combination of folic acid, 5‐FU, SAHA, and plasmid DNA pCIneoGFP for targeted delivery to CRC cells. Biophysical characterizations of therapeutic loaded dendrimers and their complexes with pCIneoGFP were performed by: dynamic light scattering, fluorescence spectroscopy, and gel electrophoresis. Further, cellular analyses of dendriplexes demonstrated high transfection efficiency and anticancer activity on HCT 116 and HT‐29 cell lines. We have successfully developed a multifunctional nanocarrier platform based on PAMAM dendrimers, offering a promising tool for targeted combination therapy of CRC.
- 17 November 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (11) , e202400362
Open AccessMultifunctional PAMAM Dendrimers Carrying SAHA, 5‐FU, and a Therapeutic Gene for Targeted Co‐Delivery Toward Colorectal Cancer Cells
A promising approach to treat colorectal cancer (CRC) involves combining chemotherapy, epigenetics, and gene therapy to combat drug resistance. Multifunctional nanocarriers have emerged as a valuable tool for targeted CRC therapy. By delivering multiple treatments directly to cancer cells, these nanocarriers offer the potential for improved outcomes and reduced side effects. PAMAM‐based dendrimers were functionalized with a unique combination of folic acid, 5‐FU, SAHA, and plasmid DNA pCIneoGFP for targeted delivery to CRC cells. Biophysical characterizations of therapeutic loaded dendrimers and their complexes with pCIneoGFP were performed by: dynamic light scattering, fluorescence spectroscopy, and gel electrophoresis. Further, cellular analyses of dendriplexes demonstrated high transfection efficiency and anticancer activity on HCT 116 and HT‐29 cell lines. We have successfully developed a multifunctional nanocarrier platform based on PAMAM dendrimers, offering a promising tool for targeted combination therapy of CRC.
- Open Access
- 11 March 2024
- Published by Wiley in ChemistryOpen
- Vol. 13 (9) , e202300254
Development and Characterization of Plant‐derived Aristatoside C and Davisianoside B Saponin‐loaded Phytosomes with Suppressed Hemolytic Activity
Saponins are glycosides widely distributed in the plant kingdom and have many pharmacological activities. However, their tendency to bind to cell membranes can cause cell rupture, limiting their clinical use. In the previous study, aristatoside C and davisianoside B were isolated from Cephalaria species. Cytotoxicity assays showed that they are more active on A‐549 cell lines than doxorubicin but caused hemolysis. In the current research, aristatoside C and davisianoside B were loaded to phytosomes called ALPs and DLPs respectively, and characterized for particle size, zeta potential, encapsulation efficiency, release kinetic, hemolytic activity, and cytotoxicity on A‐549 cell line. DLPs maintained the cytotoxic activity of the free saponins against A‐549 cells with IC50 of 9,64±0,02 μg/ml but dramatically reduced their hemolytic activity. Furthermore, temperature and time‐dependent stability studies based on the size and zeta potential of ALPs and DLPs revealed that the phytosomes have sustained release properties over 2 weeks. Overall, DLPs displayed cytotoxicity against A‐549 cells with minimal hemolysis and sustained release, highlighting their potential as nanotherapeutics for clinical applications.
- 11 March 2024
- Published by Wiley in ChemistryOpen
- Vol. 13 (9) , e202300254
Open AccessDevelopment and Characterization of Plant‐derived Aristatoside C and Davisianoside B Saponin‐loaded Phytosomes with Suppressed Hemolytic Activity
Saponins are glycosides widely distributed in the plant kingdom and have many pharmacological activities. However, their tendency to bind to cell membranes can cause cell rupture, limiting their clinical use. In the previous study, aristatoside C and davisianoside B were isolated from Cephalaria species. Cytotoxicity assays showed that they are more active on A‐549 cell lines than doxorubicin but caused hemolysis. In the current research, aristatoside C and davisianoside B were loaded to phytosomes called ALPs and DLPs respectively, and characterized for particle size, zeta potential, encapsulation efficiency, release kinetic, hemolytic activity, and cytotoxicity on A‐549 cell line. DLPs maintained the cytotoxic activity of the free saponins against A‐549 cells with IC50 of 9,64±0,02 μg/ml but dramatically reduced their hemolytic activity. Furthermore, temperature and time‐dependent stability studies based on the size and zeta potential of ALPs and DLPs revealed that the phytosomes have sustained release properties over 2 weeks. Overall, DLPs displayed cytotoxicity against A‐549 cells with minimal hemolysis and sustained release, highlighting their potential as nanotherapeutics for clinical applications.
- Top Cited Papers
- 1 February 2021
- Published by Elsevier in Nano Today
- Vol. 36
Tissue adhesives: From research to clinical translation
- 1 February 2021
- Published by Elsevier in Nano Today
- Vol. 36
Top Cited PapersTissue adhesives: From research to clinical translation